SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000318306-00-000011
Filing Date
2000-05-25
Accepted
2000-05-25 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 S-3 81719
2 OPINION OF BINGHAM DANA LLP EX-5.1 2832
3 CONSENT OF GRANT THORNTON LLP EX-23.(B) 762
4 CONSENT OF KPMG LLP EX-23.(C) 763
5 CONSENT OF SMITH ANGLIN & CO. CPAS EX-23.(D) 435
  Complete submission text file 0000318306-00-000011.txt   88524
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-37786 | Film No.: 643373
SIC: 2834 Pharmaceutical Preparations